People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of the risks and how to mitigate them.

A long-time ADA member offers their firsthand perspective on an incident at this year’s Scientific Sessions that sparked debate about leadership, scientific discourse, and accountability.

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

When the media seeks “unity” with politicians, we’re all in trouble

Allowing patients to keep using their personal diabetes technology during hospitalization improves glycemic control and reduces length of stay.

Read clinically focused news coverage of key developments from AACE 2026.

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are moving forward.

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Those who were misdiagnosed had higher healthcare utilization, suggesting potential benefits of broader autoantibody screening.

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment.

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment.

Dr Anne Peters discusses clinical concerns related to insulin delivery system sensors.

Findings underscore the risk for graded exercise in people with post-exertional malaise and point to careful activity pacing as a safer approach.

Increasing evidence suggests fasting for lipid tests may not be necessary and could be dangerous for some diabetes patients, but an overall shift away from the practice will likely take time.

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare for the challenges that accompany aging with this condition.